跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
优拓比 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Selexipag Tablets
Approved
化学药品
Selexipag Tablets
Actelion Pharmaceuticals Ltd
🇨🇳 National Medical Products Administration
Approval Date
Dec 7, 2018
Approval ID
7MaoUJigBxe
Company
Actelion Pharmaceuticals Ltd
Type
化学药品
Approval Details
Approval Id
7MaoUJigBxe
Approval Number
H20180085
Generic Name
司来帕格片
Generic Name En
Selexipag Tablets
Trade Name
优拓比
Drug Type
化学药品
Dosage Form
片剂
Strength
1.6mg
Reg Date
2018-12-07
Expired Date
2023-12-06
Company Name
Actelion Pharmaceuticals Ltd
Company Address
Gewerbestrasse 16, 4123 Allschwil, Switzerland
Production Company Name
Excella GmbH & Co. KG
Production Company Address
Nürnberger Str.12, 90537, Feucht, Germany
Company Detail Path
/organization/actelion-pharmaceuticals-ltd
Production Company Detail Path
/organization/excella-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 7, 2018
Approval ID
7MaoUJigBxe
Type
化学药品
Back to NMPA Approvals